Education
About Us
Working with TipRanks
Follow Us
PRXV - ETF AI Analysis
Top Page
Praxis Impact Large Cap Value ETF (PRXV)
Rating:72Outperform
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.
Mix of Defensive and Growth-Oriented Holdings
Top positions include steady consumer and health care names alongside faster-growing technology stocks, offering a balance of stability and growth potential.
Solid Recent Performance Trend
The ETF has shown positive returns over the past month, three months, and year to date, indicating recent momentum in its strategy.
Negative Factors
Heavy U.S. Market Concentration
With almost all assets in U.S. stocks, the fund offers little geographic diversification and is highly tied to the U.S. market’s fortunes.
Notable Weakness in Some Top Financial Holdings
Several large financial stocks in the top holdings have been weak so far this year, which can drag on overall returns if the sector stays under pressure.
Moderate Expense Ratio
The fund’s fee is not especially low for a large-cap ETF, which slightly reduces the net return investors keep over time.
PRXV vs. SPDR S&P 500 ETF (SPY)
AUM65.48M
RegionNorth America
Expense Ratio0.36%
Beta0.66
IssuerPraxis
Inception DateApr 08, 2025
Dividend Yield1.11%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume7,337
30 Day Avg. Volume7,222
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
36.15Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering274
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PRXV Summary
The Praxis Impact Large Cap Value ETF (PRXV) invests mainly in large, established U.S. companies that appear undervalued and also meet certain environmental, social, and governance (ESG) standards. It does not track a specific index, but focuses on value stocks across many sectors like financials, health care, and technology. Well-known holdings include JPMorgan Chase and Johnson & Johnson. Someone might invest in this ETF to seek long-term growth while aligning their money with their values and getting broad diversification. A key risk is that value stocks and the overall stock market can go up and down, sometimes sharply.
How much will it cost me?The Praxis Impact Large Cap Value ETF (PRXV) has an expense ratio of 0.36%, which means you’ll pay $3.60 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed and focuses on socially responsible investing, which requires more research and oversight. It’s a good option if you value ethical considerations alongside financial returns.
What would affect this ETF?The PRXV ETF, with its focus on large-cap value stocks and ESG criteria, could benefit from increased investor interest in socially responsible investing and strong performance in sectors like financials and healthcare. However, it may face challenges if economic conditions weaken, particularly in North America, or if regulatory changes impact ESG-focused investments. Sector-specific risks, such as volatility in energy or technology, could also influence its future performance.
PRXV Top 10 Holdings
PRXV leans heavily on U.S. financials and health care, with JPMorgan and Bank of America acting as solid but not spectacular anchors—recent gains are modest and earlier in the year they’ve been more of a headwind. The real spark comes from Micron, where booming AI-related demand has the stock powering higher and giving the fund a tech tailwind despite its value tilt. Steady climbers like Johnson & Johnson, Walmart, and Coca-Cola add a defensive backbone, while ConocoPhillips’ upswing in energy helps round out performance with a cyclical boost.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| JPMorgan Chase | 3.48% | $2.28M | $762.96B | 25.62% | 72 Outperform | |
| Johnson & Johnson | 2.70% | $1.76M | $583.29B | 48.50% | 78 Outperform | |
| Walmart | 2.37% | $1.55M | $998.90B | 48.32% | 78 Outperform | |
| Micron | 2.13% | $1.39M | $456.23B | 327.22% | 79 Outperform | |
| Procter & Gamble | 2.04% | $1.34M | $349.76B | -10.73% | 69 Neutral | |
| AbbVie | 1.79% | $1.17M | $398.49B | 6.53% | 66 Neutral | |
| Home Depot | 1.56% | $1.02M | $337.41B | -2.40% | 66 Neutral | |
| Conocophillips | 1.54% | $1.00M | $147.00B | 25.02% | 78 Outperform | |
| Coca-Cola | 1.52% | $991.10K | $333.78B | 11.48% | 75 Outperform | |
| Bank of America | 1.45% | $949.78K | $338.24B | 18.80% | 72 Outperform |
PRXV Technical Analysis
Neutral
―
Price Trends
31.77
Negative
30.77
Positive
29.64
Positive
Market Momentum
-0.11
Positive
32.33
Neutral
18.36
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PRXV, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 32.26, equal to the 50-day MA of 31.77, and equal to the 200-day MA of 29.64, indicating a neutral trend. The MACD of -0.11 indicates Positive momentum. The RSI at 32.33 is Neutral, neither overbought nor oversold. The STOCH value of 18.36 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PRXV.
PRXV Peer Comparison
Comparison Results
Performance Comparison
PRXV
Praxis Impact Large Cap Value ETF
31.11
5.49
21.43%
DVAL
BrandywineGLOBAL - Dynamic US Large Cap Value ETF
―
―
―
MAVF
Matrix Advisors Value ETF
―
―
―
ITAN
Sparkline Intangible Value ETF
―
―
―
DHLX
Diamond Hill Large Cap Concentrated ETF
―
―
―
FLCV
Federated Hermes MDT Large Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents